title: Patient-derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment.
abstract: Pseudomyxoma peritonei (PMP) is a neoplastic syndrome characterized by peritoneal tumor implants with copious mucinous ascites. The standard of care for PMP patients is aggressive cytoreductive surgery performed in conjunction with heated intraperitoneal chemotherapy. Not all patients are candidates for these procedures and a majority of the patients will have recurrent disease. In addition to secreted mucin, inflammation and fibrosis are central to PMP pathogenesis but the molecular processes that regulate tumor-stromal interactions within the peritoneal tumor microenvironment remain largely unknown. This knowledge is critical not only to elucidate PMP pathobiology but also to identify novel targets for therapy. Here, we report the generation of patient-derived xenograft (PDX) mouse models for PMP and assess the ability of these models to replicate the inflammatory peritoneal microenvironment of human PMP patients. PDX mouse models of low- and high-grade PMP were generated and were of a similar histopathology as human PMP. Cytokines previously shown to be elevated in human PMP were also elevated in PDX ascites. Significant differences in IL-6 and IL-8/KC/MIP2 were seen between human and PDX ascites. Interestingly, these cytokines were mostly secreted by mouse-derived, tumor-associated stromal cells rather than by human-derived PMP tumor cells. Our data suggest that the PMP PDX mouse models are especially suited to the study of tumor-stromal interactions that regulate the peritoneal inflammatory environment in PMP as the tumor and stromal cells in these mouse models are of human and murine origins, respectively. These mouse models are therefore, likely to be useful in vivo surrogates for testing and developing novel therapeutic treatment interventions for PMP.
authors.affiliation: Department of Surgery, Creighton University, 2500 California Plaza, Omaha, Nebraska, 68178.
authors.forename: Murali R
authors.initials: MR
authors.lastname: Kuracha
authors.affiliation: Department of Surgery, Creighton University, 2500 California Plaza, Omaha, Nebraska, 68178.
authors.forename: Peter
authors.initials: P
authors.lastname: Thomas
authors.affiliation: Department of Surgery, Creighton University, 2500 California Plaza, Omaha, Nebraska, 68178.
authors.forename: Brian W
authors.initials: BW
authors.lastname: Loggie
authors.affiliation: Department of Surgery, Creighton University, 2500 California Plaza, Omaha, Nebraska, 68178.|Department of Biomedical Sciences, Creighton University, 2500 California Plaza, Omaha, Nebraska, 68178.
authors.forename: Venkatesh
authors.initials: V
authors.lastname: Govindarajan
mesh_terms: D000818:Animals; D018925:Chemokines / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism; D004195:Disease Models, Animal; D064593:Heterografts; D006801:Humans; D007150:Immunohistochemistry; D007249:Inflammation / Q000378:metabolism / Q000473:pathology*; D018836:Inflammation Mediators / Q000378:metabolism; D051379:Mice; D060787:Neoplasm Grading; D010534:Peritoneal Neoplasms / Q000378:metabolism / Q000473:pathology*; D011553:Pseudomyxoma Peritonei / Q000378:metabolism / Q000473:pathology*; D059016:Tumor Microenvironment
chemical_list: D018925:Chemokines; D016207:Cytokines; D018836:Inflammation Mediators
keywords: Ascites; chemokines; cytokines; model; mouse; peritonei; pseudomyxoma; xenograft
references.citation: Ann Surg Oncol. 2015 Aug;22(8):2799-805
references.pmid: 25572681
references.citation: Cancer Res. 1972 Aug;32(8):1663-6
references.pmid: 5044130
references.citation: Ann Surg Oncol. 2006 May;13(5):624-34
references.pmid: 16538401
references.citation: Innate Immun. 2008 Apr;14(2):117-24
references.pmid: 18713728
references.citation: Br J Cancer. 2006 Nov 6;95(9):1258-64
references.pmid: 17031402
references.citation: Semin Immunol. 2014 Feb;26(1):48-53
references.pmid: 24613573
references.citation: Virology. 2007 Feb 5;358(1):98-108
references.pmid: 16996102
references.citation: Am J Physiol Gastrointest Liver Physiol. 2012 Nov 15;303(10):G1087-95
references.pmid: 23019193
references.citation: Anticancer Res. 2009 Oct;29(10):4051-5
references.pmid: 19846950
references.citation: ISRN Oncol. 2013 Oct 09;2013:859154
references.pmid: 24224100
references.citation: J Leukoc Biol. 2010 Mar;87(3):501-8
references.pmid: 20007247
references.citation: Front Oncol. 2013 Sep 25;3:256
references.pmid: 24093089
references.citation: Am J Surg Pathol. 1995 Dec;19(12):1390-408
references.pmid: 7503361
references.citation: Cold Spring Harb Protoc. 2014 Jul 01;2014(7):694-708
references.pmid: 24987146
references.citation: Am Surg. 2013 Nov;79(11):1171-6
references.pmid: 24165252
references.citation: Biochem Biophys Res Commun. 2003 Jan 24;300(4):813-8
references.pmid: 12559945
references.citation: Clin Cancer Res. 2015 Mar 15;21(6):1248-57
references.pmid: 25589616
references.citation: J Clin Oncol. 2012 Jul 10;30(20):2449-56
references.pmid: 22614976
references.citation: Cancer Cell. 2012 Mar 20;21(3):309-22
references.pmid: 22439926
references.citation: Curr Oncol. 2011 Apr;18(2):e84-96
references.pmid: 21505593
references.citation: Histopathology. 2006 Oct;49(4):381-7
references.pmid: 16978201
references.citation: BMC Cancer. 2007 Jun 30;7:116
references.pmid: 17603904
references.citation: Ann Surg Oncol. 2014 May;21(5):1441-7
references.pmid: 24046117
references.citation: Hum Pathol. 2010 Aug;41(8):1109-19
references.pmid: 20338618
references.citation: J Am Coll Surg. 2004 Jun;198(6):999-1011
references.pmid: 15194082
references.citation: Cancer Med. 2016 Apr;5(4):711-9
references.pmid: 26833741
references.citation: Cancer Res. 2013 Sep 1;73(17):5315-9
references.pmid: 23733750
references.citation: Cancer Cell. 2011 Dec 13;20(6):691-3
references.pmid: 22172716
references.citation: Am J Obstet Gynecol. 1974 Aug 1;119(7):991-4
references.pmid: 4276313
references.citation: Am J Pathol. 2002 Aug;161(2):551-64
references.pmid: 12163380
references.citation: Am J Surg Pathol. 2006 May;30(5):551-9
references.pmid: 16699309
references.citation: Int J Exp Pathol. 2010 Aug;91(4):357-67
references.pmid: 20586814
references.citation: Oncol Lett. 2011 Jul;2(4):583-589
references.pmid: 22848232
references.citation: BMC Dev Biol. 2010 Jan 27;10:13
references.pmid: 20105280
references.citation: Oncotarget. 2015 Oct 20;6(32):33329-44
references.pmid: 26436698
references.citation: J Surg Oncol. 2012 Dec;106(7):911-7
references.pmid: 22585683